Paper Title

Case study on the effect of T-AYU-HM Premium along with modern medicines in Covid-19 patient with comorbidities

Authors

Atul Desai , Kavita Desai , Hemshree Desai , Rutvij Desai , Chirag Desai

Keywords

Covid-19, T-AYU-HM Premium, D-Dimer, CRP, ESR, Comorbidities

Abstract

Patients with existing comorbidities or those who are elderly have a poor prognosis. Generally, existing comorbidities in covid-19 patients exhibit increased chances of mortality and require a longer treatment period. This pandemic has now reached a stage where there is a dire need to incorporate an integrated treatment approach for combating such conditions. Here, we present a case study on the clinical outcome of the integrated treatment approach in Covid-19 patients with pre-existing comorbidities. The patient is a known case of type 2 diabetes mellitus, hypertension, hypothyroidism, and arthritis. He was on his medication at the time. On infection with coronavirus, he was advised of the standard treatment plan and strict home quarantine. He presented to the covid-19 healthcare center with complaints of weakness, breathlessness on exertion, cough, loss of appetite. On examination, he had a 93% oxygen saturation and had hematological findings; CRP 33.3(mg/dL), ESR 112(mm/hour), D-dimer 2470(ng/mL), LDH 2485 (Units/L), RBS 596 mg/d. He provided his informed consent to proceed with the integrated treatment approach. The integrated treatment approach along modern medicine includes T-AYU-HM Premium 600mg and Acupen 600mg thrice a day. The treatment plan has resulted in remarkable improvement in the clinical profile and the inflammatory markers of patients. It has managed the blood glucose level in the patient and preventing unwanted complications associated with it. This case study provides information about the importance of an integrated treatment approach in the treatment of Covid-19 with existing co-morbidities.

How To Cite

"Case study on the effect of T-AYU-HM Premium along with modern medicines in Covid-19 patient with comorbidities", IJSDR - International Journal of Scientific Development and Research (www.IJSDR.org), ISSN:2455-2631, Vol.6, Issue 8, page no.38 - 41, August-2021, Available :https://ijsdr.org/papers/IJSDR2108007.pdf

Issue

Volume 6 Issue 8, August-2021

Pages : 38 - 41

Other Publication Details

Paper Reg. ID: IJSDR_193582

Published Paper Id: IJSDR2108007

Downloads: 000347309

Research Area: Engineering

Country: -, -, -

Published Paper PDF: https://ijsdr.org/papers/IJSDR2108007

Published Paper URL: https://ijsdr.org/viewpaperforall?paper=IJSDR2108007

About Publisher

ISSN: 2455-2631 | IMPACT FACTOR: 9.15 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 9.15 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJSDR(IJ Publication) Janvi Wave

Article Preview

academia
publon
sematicscholar
googlescholar
scholar9
maceadmic
Microsoft_Academic_Search_Logo
elsevier
researchgate
ssrn
mendeley
Zenodo
orcid
sitecreex